Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00387153
What this trial is testing

Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory Cancer

Who this might be right for
Cancer
Myriad Therapeutics, Inc. 8
Early research (Phase 1)Study completedNCT05376345
What this trial is testing

BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Shanghai Changzheng Hospital 24
Early research (Phase 1)Study completedNCT00637039
What this trial is testing

Study of AZD8931 in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
AstraZeneca 41
Early research (Phase 1)Study completedNCT00927875
What this trial is testing

BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Bristol-Myers Squibb 5
Not applicableStudy completedNCT03464045
What this trial is testing

Empa PASS on Urinary Tract Malignancies

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 344,995
Early research (Phase 1)Study completedNCT00060645
What this trial is testing

Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)

Who this might be right for
TumorsLymphomaMultiple Myeloma
Merck Sharp & Dohme LLC 33
Not applicableUnknownNCT02803619
What this trial is testing

A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis

Who this might be right for
Non-small Cell Lung CancerLeptomeningeal Metastasis
Peking Union Medical College Hospital 60
Post-approval studies (Phase 4)Enrolling By InvitationNCT02670161
What this trial is testing

Quality Improvement and Practice Based Research in Neurology Using the EMR

Who this might be right for
Brain TumorsEpilepsyMigraine+7 more
Endeavor Health 3,300
Testing effectiveness (Phase 2)Study completedNCT02428270
What this trial is testing

GSK2256098 and Trametinib in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdenocarcinoma
University Health Network, Toronto 16
Testing effectiveness (Phase 2)Looking for participantsNCT07760454
What this trial is testing

A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
UCARsgen Biotech Limited 68
Not applicableWithdrawnNCT03001505
What this trial is testing

Registry for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Duke University
Not applicableTemporarily pausedNCT05820633
What this trial is testing

Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer.

Who this might be right for
Prostate CancerNode; ProstateRadiotherapy Side Effect
CHU de Quebec-Universite Laval 500
Early research (Phase 1)Study completedNCT00477035
What this trial is testing

Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies

Who this might be right for
LeukemiaMultiple Myeloma
Sally Arai 22
Early research (Phase 1)Looking for participantsNCT06582017
What this trial is testing

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Who this might be right for
Ovarian CancerPancreas CancerUrothelial Carcinoma+6 more
Nammi Therapeutics Inc 100
Testing effectiveness (Phase 2)Study completedNCT05347485
What this trial is testing

JNJ-68284528 Out-of-Specification (OOS) for Commercial Release in Participants With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Scientific Affairs, LLC 86
Large-scale testing (Phase 3)UnknownNCT00003725
What this trial is testing

Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

Who this might be right for
Bladder Cancer
Anthra Pharmaceuticals 300
Testing effectiveness (Phase 2)Looking for participantsNCT07291076
What this trial is testing

Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Bristol-Myers Squibb 198
Not applicableLooking for participantsNCT06197776
What this trial is testing

Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC

Who this might be right for
Multi-omics TechniqueNasopharyngeal CarcinomaRecurrent and Metastatic Nasopharyngeal Carcinoma+1 more
Sun Yat-sen University 50
Not applicableEnded earlyNCT02654340
What this trial is testing

Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

Who this might be right for
Hypomelanotic MaculesFacial AngiofibromaShagreen Patches+6 more
CENTOGENE GmbH Rostock 20
Not applicableAvailableNCT01916148
What this trial is testing

18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia

Who this might be right for
Congenital Hyperinsulinism (CHI)Beckwith-Wiedemann SyndromeInsulinoma
Children's Hospital of Philadelphia
Next Page